These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 26187975)

  • 21. Four-year randomized prospective comparison of percutaneous ePTFE/nitinol self-expanding stent graft versus prosthetic femoral-popliteal bypass in the treatment of superficial femoral artery occlusive disease.
    McQuade K; Gable D; Pearl G; Theune B; Black S
    J Vasc Surg; 2010 Sep; 52(3):584-90; discussion 590-1, 591.e1-591.e7. PubMed ID: 20598480
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recent advances in self-expanding stents for use in the superficial femoral and popliteal arteries.
    Aghel A; Armstrong EJ
    Expert Rev Cardiovasc Ther; 2014 Jul; 12(7):833-42. PubMed ID: 24830846
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Laser atherectomy for lower extremity revascularization: An adjunctive endovascular treatment option.
    Zhou W; Bush RL; Lin PH; Peden EK; Lumsden AB
    Vasc Endovascular Surg; 2006; 40(4):268-74. PubMed ID: 16959719
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Femoropopliteal artery stent placement: evaluation of long-term success.
    Strecker EP; Boos IB; Göttmann D
    Radiology; 1997 Nov; 205(2):375-83. PubMed ID: 9356617
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intravascular ultrasound guided directional atherectomy versus directional atherectomy guided by angiography for the treatment of femoropopliteal in-stent restenosis.
    Krishnan P; Tarricone A; K-Raman P; Majeed F; Kapur V; Gujja K; Wiley J; Vasquez M; Lascano RA; Quiles KG; Distin T; Fontenelle R; Atallah-Lajam F; Kini A; Sharma S
    Ther Adv Cardiovasc Dis; 2018 Jan; 12(1):17-22. PubMed ID: 29265002
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stent and Non-Stent Based Outcomes of Infrainguinal Peripheral Artery Interventions From the Multicenter XLPAD Registry.
    Banerjee S; Pershwitz G; Sarode K; Mohammad A; Abu-Fadel MS; Baig MS; Tsai S; Little BB; Gigliotti OS; Soto-Cora E; Foteh MI; Rodriguez G; Klein A; Addo T; Luna M; Shammas NW; Prasad A; Brilakis ES
    J Invasive Cardiol; 2015 Jan; 27(1):14-8. PubMed ID: 25589695
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Paclitaxel-Eluting Balloon Versus Standard Balloon Angioplasty in In-Stent Restenosis of the Superficial Femoral and Proximal Popliteal Artery: 1-Year Results of the PACUBA Trial.
    Kinstner CM; Lammer J; Willfort-Ehringer A; Matzek W; Gschwandtner M; Javor D; Funovics M; Schoder M; Koppensteiner R; Loewe C; Ristl R; Wolf F
    JACC Cardiovasc Interv; 2016 Jul; 9(13):1386-92. PubMed ID: 27388828
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Randomized comparison of ePTFE/nitinol self-expanding stent graft vs prosthetic femoral-popliteal bypass in the treatment of superficial femoral artery occlusive disease.
    McQuade K; Gable D; Hohman S; Pearl G; Theune B
    J Vasc Surg; 2009 Jan; 49(1):109-15, 116.e1-9; discussion 116. PubMed ID: 19028055
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of stent-grafts for prevention and treatment of restenosis.
    Kwa AT; Yeo KK; Laird JR
    J Cardiovasc Surg (Torino); 2010 Aug; 51(4):579-89. PubMed ID: 20671643
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Heparin-bonded covered stents versus bare-metal stents for complex femoropopliteal artery lesions: the randomized VIASTAR trial (Viabahn endoprosthesis with PROPATEN bioactive surface [VIA] versus bare nitinol stent in the treatment of long lesions in superficial femoral artery occlusive disease).
    Lammer J; Zeller T; Hausegger KA; Schaefer PJ; Gschwendtner M; Mueller-Huelsbeck S; Rand T; Funovics M; Wolf F; Rastan A; Gschwandtner M; Puchner S; Ristl R; Schoder M
    J Am Coll Cardiol; 2013 Oct; 62(15):1320-7. PubMed ID: 23831445
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety and 1-year revascularization outcome of SilverHawk atherectomy in treating in-stent restenosis of femoropopliteal arteries: a retrospective review from a single center.
    Shammas NW; Shammas GA; Helou TJ; Voelliger CM; Mrad L; Jerin M
    Cardiovasc Revasc Med; 2012; 13(4):224-7. PubMed ID: 22575073
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safety and efficacy of directional atherectomy for the treatment of in-stent restenosis of the femoropopliteal artery.
    Trentmann J; Charalambous N; Djawanscher M; Schäfer J-; Jahnke T
    J Cardiovasc Surg (Torino); 2010 Aug; 51(4):551-60. PubMed ID: 20671639
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endovascular interventions in iliac and infrainguinal occlusive artery disease.
    Ruef J; Hofmann M; Haase J
    J Interv Cardiol; 2004 Dec; 17(6):427-35. PubMed ID: 15546296
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Incidence and clinical significance of distal embolization during percutaneous interventions involving the superficial femoral artery.
    Lam RC; Shah S; Faries PL; McKinsey JF; Kent KC; Morrissey NJ
    J Vasc Surg; 2007 Dec; 46(6):1155-9. PubMed ID: 18154991
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combination of mechanical atherectomy and drug-eluting balloons for femoropopliteal in-stent restenosis.
    Beschorner U; Zeller T
    J Cardiovasc Surg (Torino); 2014 Jun; 55(3):347-9. PubMed ID: 24755703
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment options for coronary stent restenosis.
    Dauerman HL; Cohen DJ
    Compr Ther; 1999; 25(8-10):403-10. PubMed ID: 10520442
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drug-coated balloon angioplasty after directional atherectomy improves outcome in restenotic femoropopliteal arteries.
    Sixt S; Carpio Cancino OG; Treszl A; Beschorner U; Macharzina R; Rastan A; Krankenberg H; Neumann FJ; Zeller T
    J Vasc Surg; 2013 Sep; 58(3):682-6. PubMed ID: 23755977
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictors of restenosis in the use of helical interwoven nitinol stents to treat femoropopliteal occlusive disease.
    Chan YC; Cheng SW; Cheung GC
    J Vasc Surg; 2015 Nov; 62(5):1201-9. PubMed ID: 26169015
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Should We Routinely Stent the Femoropopliteal Artery? An Interventionalist's Perspective.
    Shammas NW; Banerjee S
    J Invasive Cardiol; 2015 Nov; 27(11):E258-61. PubMed ID: 26524213
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery: twelve-month results from the RESILIENT randomized trial.
    Laird JR; Katzen BT; Scheinert D; Lammer J; Carpenter J; Buchbinder M; Dave R; Ansel G; Lansky A; Cristea E; Collins TJ; Goldstein J; Jaff MR;
    Circ Cardiovasc Interv; 2010 Jun; 3(3):267-76. PubMed ID: 20484101
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.